ReShape Lifesciences(R) Announces Pricing of $2.6 Million Public Offering
ReShape Lifesciences(R) Announces Pricing of $2.6 Million Public Offering GlobeNewswire June 09, 2025 IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) — ReShape Lifesciences(R) (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public offering of 1,054,604 shares of common stock at a […]